Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Experience of long-term use of botulinum toxin type A-hemagglutinin complex in the rehabilitation of patients who have suffered ischemic stroke resulting in focal spasticity: interim results
https://doi.org/10.33667/2078-5631-2025-15-31-35
Abstract
Focal post-stroke spasticity significantly impairs the functioning and quality of life of patients. Therapy with botulinum toxin type A – hemagglutinin complex is an effective method of stabilizing the level of post-stroke spasticity, reduces the severity of restrictions on self-care and work activity of patients. Purpose of the study: to evaluate the effectiveness of long-term use of botulinum toxin therapy in the rehabilitation of patients with focal post- stroke spasticity.
Materials and methods. The study included clinical data of 24 patients who had suffered a stroke and were receiving treatment within the third stage of rehabilitation. Two groups of patients were identified: the main group (n=12) received treatment with the botulinum toxin type A hemagglutinin complex (the drug «Dysport®») for 12 years (a total of 30–45 courses of injection treatment per patient over 12 years of observation) and symptomatic treatment of focal spasticity, physical rehabilitation courses (therapeutic exercise classes, medical massage, physiotherapy), and the control group (n=12) received physical rehabilitation courses. The research method was a one-time retrospective analysis of medical data, followed by an annual assessment of the degree of limitations in life activities, motor function impairment, dynamics of the level of focal spasticity, and severity of pain syndrome during 12 years of observation. Results. Over 12 years of observation of patients in both groups, there was a significant improvement in the quality of life, a decrease in motor disorders, and a decrease in pain in patients in the main group.
Conclusions. Therapy of focal post-stroke spasticity with botulinum toxin type A – hemagglutinin complex (the drug «Dysport»®) is effective as a therapy for reducing pain syndrome, improving the quality of life and self-care of patients in the long term.
About the Authors
V. V. Gusev
Ural State Medical University; Ural Federal University named after the first President of Russia B. N. Yeltsin; Central City Clinical Hospital No. 23 of Yekaterinbur»
Russian Federation
Russian Federation
Gusev Vadim V., DM Sci (habil.), associate professor, head of Dept of Neurology and Neurosurgery; leading researcher at Neurotechnology Laboratory; neurologist at Dept of Neurology
D. A. Medvedeva
“SMT-CLINIC” LLC
Russian Federation
Russian Federation
Medvedeva Daria A., neurologist
References
1. Игнатьева В. И., Вознюк И. А., Шамалов Н. А., Резник А. В., Виницкий А. А., Деркач Е. В. Социально-экономическое бремя инсульта в Российской Федерации. Журнал неврологии и психиатрии им. С. С. Корсакова. 2023; 123 (8–2): 5–15.
2. Ignatyeva V. I., Voznyuk I. A., Shamalov N. A., Reznik A. V., Vinitsky A. A., Derkach E. V. Socioeconomic Burden of Stroke in the Russian Federation. Journal of Neurology and Psychiatry named after S. S. Korsakov. 2023; 123 (8–2): 5–15. (In Russ.). https://doi.org/10.17116/jnevro20231230825
3. Хатькова С. Е., Гильвег А. С. Моделирование отдаленных результатов и риска смерти у пациентов с постинсультной спастичностью при проведении инъекций абоботулотоксина в структуре реабилитации. Неврология, нейропсихиатрия, психосоматика. 2024; 16 (2): 60–68.
4. Khatkova S. E., Gilveg A. S. Modeling Long-term Outcomes and Mortality Risk in Patients with Post-Stroke Spasticity Undergoing Botulinum Toxin Injections within Rehabilitation. Neurology, Neuropsychiatry, and Psychosomatics. 2024; 16 (2): 60–68. (In Russ.). https://doi.org/10.14412/2074-2711-2024-2-60-68
5. Caty G. D., Detrembleur C., Bleyenheuft C., Deltombe T., Lejeune T. M. Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients. Stroke. 2009; 40: 2589–2591. https://doi.org/10.1161/STROKEAHA.108.544346
6. Очаговое повреждение головного мозга у взрослых: синдром спастичности. Клинические рекомендации. М., 2016. 4 с. Focal brain injury in adults: spasticity syndrome. Clinical guidelines. М., 2016. 4 p. (In Russ.).
7. Gracies J. M., Brashear A., Jech R., McAllister P., Banach M., Valkovic P., Walker H., Marciniak C., Deltombe T., Skoromets A., Khatkova S., Edgley S., Gul F., Catus F., De Fer B. B., Vilain C., Picaut P. Safety and efficacy of abobotulinumtoxinA for hemiparesisin adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. The Lancet. Neurology. 2015; 14 (10): 992-1001. https://doi.org/10.1016/S 1474–4422 (15) 00216-1
8. Gracies JM, O’Dell M, Vecchio M. et al. International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity. Muscle Nerve. 2018 Feb; 57 (2): 245–54. DOI: 10.1002/mus.25721. Epub 2017 Aug 13
9. Rosales R. L., Chua-Yap A. S. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm (Vienna). 2008;115 (4): 617–23. https://doi.org/10.1007/s00702-007-0869-3
10. Turner-Stokes L., Fheodoroff K., Jacinto J., Maisonobe P. Results from the Upper Limb International Spasticity Study-II (ULISII): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management. BMJ Open. 2013; 3 (6): 1–12. https://doi.org/10.1136/bmjopen-2013-002771
11. Demetrios M., Gorelik A., Louie J., Brand C., Baguley I., Khan F. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke. J Rehabil Med. 2014; 46 (8): 730–737. https://doi. org/10.2340/16501977–1842
12. Fheodoroff K, Danchenko N, Whalen J. et al. Modelling Long-Term Outcomes and Risk of Death for Patients with Post-Stroke Spasticity Receiving Abobotulinumtoxina Treatment and Rehabilitation Therapy. J Rehabil Med. 2022 Aug 24; 54: jrm00303. DOI: 10.2340/jrm.v54.2422
Review
For citations:
Gusev V.V., Medvedeva D.A. Experience of long-term use of botulinum toxin type A-hemagglutinin complex in the rehabilitation of patients who have suffered ischemic stroke resulting in focal spasticity: interim results. Medical alphabet. 2025;(15):31-35. (In Russ.) https://doi.org/10.33667/2078-5631-2025-15-31-35
Views:
24
Email this article 